HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Sebaceous adenocarcinoma — Clinical Guidelines

Overview

Sebaceous adenocarcinoma is a rare and aggressive malignant neoplasm arising from sebaceous glands, often associated with sebaceous lesions and syndromes like Muir-Torre syndrome. 3 4

Diagnosis

Presence of sebaceous lesions (e.g., nevus sebaceous of Jadassohn, sebaceous adenoma) 3

Clinical suspicion based on characteristic skin findings and associated systemic symptoms 5

Skin biopsy for histopathological confirmation showing malignant transformation 5

Consider screening for underlying visceral malignancies in suspected Muir-Torre syndrome 4

Management

Surgical excision with clear margins is the primary treatment 3

Adjuvant therapies (e.g., chemotherapy, radiation) may be considered based on stage and metastasis 3 (Evidence: Expert opinion)

Regular follow-up and intensive cancer screening recommended for patients with Muir-Torre syndrome 4 (Evidence: Moderate)

Special Populations

Pediatrics: Management varies; some advocate for excision in childhood due to malignancy risk, while others recommend monitoring 1

Comorbidities: Patients with suspected Muir-Torre syndrome require comprehensive screening for visceral malignancies 4 (Evidence: Moderate)

Key Recommendations

Excision of sebaceous lesions should be considered based on clinical risk factors and expert opinion, though routine childhood excision for malignancy prevention is debated 1 (Evidence: Expert opinion)

Patients with sebaceous neoplasms should undergo screening for Muir-Torre syndrome, including visceral malignancy checks, especially if there is a family history or additional cutaneous findings 4 (Evidence: Moderate)

Thorough physical examination, including evaluation of specific skin lesions, is crucial for diagnosing neurocutaneous syndromes like sebaceous nevus syndrome in infants 5 (Evidence: Moderate)

References

1 Wali GN, Felton SJ, McPherson T. Management of naevus sebaceous: a national survey of UK dermatologists and plastic surgeons. Clinical and experimental dermatology 2018. link 2 Hsieh CW, Wu YH, Lin SP, Peng CC, Ho CS. Sebaceous nevus syndrome, central nervous system malformations, aplasia cutis congenita, limbal dermoid, and pigmented nevus syndrome. Pediatric dermatology 2012. link 3 Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: part I. Journal of the American Academy of Dermatology 2009. link 4 Eisen DB, Michael DJ. Sebaceous lesions and their associated syndromes: part II. Journal of the American Academy of Dermatology 2009. link 5 Visudhibhan A, Chiemchanya S, Chunharas A, Kitiviriyakul D, Visudhiphan P. Sebaceous nevus syndrome as the underlying cause of intractable seizures in a one-month-old infant. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2002. link

Sebaceous adenocarcinoma